The Effect of Bevacizumab on Wound Healing Modulation in an Experimental Trabeculectomy Model

References

• Roodhooft JM. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol 2002;283:19–25
   PubMedGoogle Scholar
• Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714–720
   PubMed Web of Science ®Google Scholar
• Palmberg P. Evidence-based target pressures: how to choose and achieve them. Int Ophthalmol Clin 2004;44:1–14
   Google Scholar
• Burr J, Azuara-Blanco A, Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2005;18:CD004399
   Google Scholar
• Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987;32:149–170
   PubMed Web of Science ®Google Scholar
• Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT. Antimetabolite-induced apoptosis in Tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci 1998;39:449–454
   PubMed Web of Science ®Google Scholar
• Seah SK, Prata JA Jr., Minckler DS, Baerveldt G, Lee PP, Heuer DK. Hypotony following trabeculectomy. J Glaucoma 1995;4:73--79
   PubMedGoogle Scholar
• Parrish R, Minckler D. ‘Late endophthalmitis’: filtering surgery time bomb? Ophthalmology 1996;103:1167–1168
   Google Scholar
• Charnock-Jones DS. Vascular endothelial growth factors (VEGFs), their receptors and their inhibition. Cell Transmissions 2005;21:1–5
   Google Scholar
• Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435–439
   PubMed Web of Science ®Google Scholar
• Kakehashi A, Inoda S, Mameuda C, Kuroki M, Jono T, Nagai R, et al. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy. Diabetes Res Clin Pract 2008;79:438–445
   PubMed Web of Science ®Google Scholar
• Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232–237
   PubMed Web of Science ®Google Scholar
• Vinores SA, Chan CC, Vinores MA, Matteson DM, Chen YS, Klein DA, et al. Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. J Neuroimmunol 1998;89:43–50
   PubMed Web of Science ®Google Scholar
• Frank RN. Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 1997;29:341–353
   PubMed Web of Science ®Google Scholar
• Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, DiPietro LA. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008;88:579–590
   PubMed Web of Science ®Google Scholar
• Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:155–158
   PubMed Web of Science ®Google Scholar
• Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363–372
   PubMed Web of Science ®Google Scholar
• Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354–356
   PubMed Web of Science ®Google Scholar
• Jonas JB, Spandau UH, Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res 2007;39:121–122
   PubMed Web of Science ®Google Scholar
• Kahook MY, Schuman JS, Noecker RJ. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging 2006;37:148–150
   PubMed Web of Science ®Google Scholar
• Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101:795–798
   PubMedGoogle Scholar
• Araujo SV, Spaeth GL, Roth SM, Starita RJ. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 1995;102:1753–1759
   PubMedGoogle Scholar
• Knapp A, Heuer DK, Stern GA, Driebe WT Jr. Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. Am J Ophthalmol 1987;103:183–187
   PubMed Web of Science ®Google Scholar
• Ustundag C, Diestelhorst M. Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy. Graefes Arch Clin Exp Ophthalmol 1998;236:734–738
   Google Scholar
• Ho QT, Kuo CJ. Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 2007;39:1349–1357
   PubMed Web of Science ®Google Scholar
• Colwell AS, Beanes SR, Soo C, Dang C, Ting K, Longaker MT, et al. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair. Plast Reconstr Surg 2005;115:204–212
   PubMed Web of Science ®Google Scholar
• Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg 1989;20:350–357
   PubMedGoogle Scholar
• Memarzadeh F, Varma R, Lin LT, Parikh JG, Dustin L, Alcaraz A, et al. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 2009;50:3233–3237
   PubMed Web of Science ®Google Scholar
• Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2009;50:5217–5225
   PubMed Web of Science ®Google Scholar
• The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996;121:349–366
   PubMed Web of Science ®Google Scholar
• Kahook MY. Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 2010;150:399–403
   PubMed Web of Science ®Google Scholar
• Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, et al. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest Ophthalmol Vis Sci 2009;50:4807–4813
   PubMed Web of Science ®Google Scholar